Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/1999

01-04-1999

Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease

Authors: Berendt W. Aichbichler, Wolfgang Petritsch, Gerhard A. Reicht, Heimo H. Wenzl, Andreas J. Eherer, Thomas A. Hinterleitner, Piet Auer-Grumbach, Guenter J. Krejs

Published in: Digestive Diseases and Sciences | Issue 4/1999

Login to get access
Metadata
Title
Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease
Authors
Berendt W. Aichbichler
Wolfgang Petritsch
Gerhard A. Reicht
Heimo H. Wenzl
Andreas J. Eherer
Thomas A. Hinterleitner
Piet Auer-Grumbach
Guenter J. Krejs
Publication date
01-04-1999
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 4/1999
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1026646816672

Other articles of this Issue 4/1999

Digestive Diseases and Sciences 4/1999 Go to the issue

OriginalPaper

Roughage Revisited (The Effect on Intestinal Function of Inert Plastic Particles of Different Sizes and Shape)

OriginalPaper

Influence of Cholestasis on Absorption of Ursodeoxycholic Acid

OriginalPaper

Assessment of Gastric Emptying (Comparison of Solid Scintigraphic Emptying and Emptying of Radiopaque Markers in Patients and Healthy Subjects)

OriginalPaper

A Prospective Study on Conversion from Sandimmune to Neoral in Stable Adult Liver Transplant Recipients

OriginalPaper

Local and Systemic Liberation of Proinflammatory Cytokines in Ulcerative Colitis

OriginalPaper

Lidocaine and Monoethylglycinexylidide Serum Determinations to Analyze Liver Function of Cirrhotic Patients After Oral Administration
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits